Pexacerfont
- Generic Name
- Pexacerfont
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H24N6O
- CAS Number
- 459856-18-9
- Unique Ingredient Identifier
- LF1VBG4ZUK
- Background
Pexacerfont has been investigated for the treatment of Alcoholism, Anxiety Disorder, Alcohol Dependence, and Alcohol-Related Disorders.
- Associated Conditions
- -
- Associated Therapies
- -
Pexacerfont for Stress-induced Food Craving
- Conditions
- First Posted Date
- 2012-08-03
- Last Posted Date
- 2016-08-18
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 31
- Registration Number
- NCT01656577
- Locations
- ๐บ๐ธ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
- Conditions
- Interventions
- First Posted Date
- 2010-10-25
- Last Posted Date
- 2016-02-02
- Target Recruit Count
- 70
- Registration Number
- NCT01227980
- Locations
- ๐บ๐ธ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
- Conditions
- Interventions
- First Posted Date
- 2007-06-01
- Last Posted Date
- 2015-10-12
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 260
- Registration Number
- NCT00481325
- Locations
- ๐บ๐ธ
Us Clinical Research Centers, Llc, Costa Mesa, California, United States
๐บ๐ธClinical Neuroscience Solutions, Inc., Memphis, Tennessee, United States
๐บ๐ธPivotal Research Centers, Mesa, Arizona, United States
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 271
- Registration Number
- NCT00135421
- Locations
- ๐บ๐ธ
Emory University, Atlanta, Georgia, United States
๐บ๐ธAlbuquerque Neuroscience, Inc., Albuquerque, New Mexico, United States
๐บ๐ธUniversity Of North Carolina At Chapel Hill, Chapel Hill, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.